Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Rosove, K. Tabsh, N. Wasserstrum, P. Howard, B. Hahn, K. Kalunian (1990)
Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodiesInternational Journal of Gynecology & Obstetrics, 34
T. Cosgriff, T. Cosgriff, B. Martin (1981)
Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis.Arthritis and rheumatism, 24 1
J. Arvieux, B. Roussel, M. Jacob, M. Colomb (1991)
Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen.Journal of immunological methods, 143 2
Rosove Rosove, Tabsh Tabsh, Wasserstrum Wasserstrum, Howard Howard, Hahn Hahn, Kalunian Kalunian (1990)
Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodiesObstet Gynecol, 75
C. Coulam, J. Stern, M. Bustillo (1994)
Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin versus placebo.Fertility and sterility, 61 2
O. Lider, E. Baharav, Y. Mekori, T. Miller, Y. Naparstek, I. Vlodavsky, I. Cohen (1989)
Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.The Journal of clinical investigation, 83 3
Trowbridge Trowbridge, Caraveo Caraveo, Green Green, Amaral Amaral, Stone Stone (1978)
Heparin‐related immune thrombocytopeniaAm J Med, 65
N. Rote (1989)
Pregnancy-associated immunological disorders.Current opinion in immunology, 1 6
C. Coulam, A. Peters, J. Mcintyre, W. Faulk (1991)
The use of IVIG for the treatment of recurrent spontaneous abortion
D. Branch, N. Rote, Dorene Dostal, J. Scott (1987)
Association of lupus anticoagulant with antibody against phosphatidylserine.Clinical immunology and immunopathology, 42 1
W. Kutteh, R. Wester, C. Kutteh (1994)
Multiples of the Median: An Alternative Method for Reporting Antiphospholipid Antibodies in Women With Recurrent Pregnancy LossObstetrics & Gynecology, 84
H. Out, H. Bruinse, G. Christiaens, M. Vliet, P. Groot, H. Nieuwenhuis, R. Derksen (1992)
A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies.American journal of obstetrics and gynecology, 167 1
N. Rote, N. Rote, D. Johnson, D. Branch (1990)
Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin.American journal of obstetrics and gynecology, 163 2
R. Kandrotas (1992)
Heparin Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 22
M. Sy, E. Schneeberger, R. McCluskey, M. Greene, R. Rosenberg, B. Benacerraf (1983)
Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity.Cellular immunology, 82 1
L. Carreras, J. Vermylen (1982)
“Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin FormationThrombosis and Haemostasis, 48
S. Shibata, P. Harpel, C. Bona, H. Fillit (1993)
Monoclonal antibodies to heparan sulfate inhibit the formation of thrombin-antithrombin III complexes.Clinical immunology and immunopathology, 67 3 Pt 1
F. Cowchock, E. Reece, D. Balaban, D. Branch, L. Plouffe (1992)
Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.American journal of obstetrics and gynecology, 166 5
(1995)
A prospective study AMERICAN JOURNAL OF REPRODUCTIVE
H. Brown (1991)
Antiphospholipid Antibodies and Recurrent Pregnancy LossClinical Obstetrics and Gynecology, 34
Triplett (1989)
Antiphospholipid antibodies and recurrent pregnancy lossAm J Reprod Immunol, 20
L. Carreras, J. Vermylen, B. Spitz, A. Assche (1981)
“LUPUS” ANTICOAGULANT AND INHIBITION OF PROSTACYCLIN FORMATION IN PATIENTS WITH REPEATED ABORTION, INTRAUTERINE GROWTH RETARDATION AND INTRAUTERINE DEATHBJOG: An International Journal of Obstetrics & Gynaecology, 88
D. Torry, J. Mcintyre, W. Faulk, P. Mcconnachie (1986)
Inhibitors of complement-mediated cytotoxicity in normal and secondary aborter sera.American journal of reproductive immunology and microbiology : AJRIM, 10 2
R. Stuart, L. Kornman, N. McHugh (1993)
A prospective study of pregnancy outcome in women screened at a routine antenatal clinic for anticardiolipin antibodiesBJOG: An International Journal of Obstetrics & Gynaecology, 100
D. Wagenknecht, J. Mcintyre (1992)
Interaction of heparin with beta 2-glycoprotein I and antiphospholipid antibodies in vitro.Thrombosis research, 68 6
J. McIntyre, C. Taylor, D. Torry, D. Wagenknecht, J. Wilson, W. Faulk (1993)
Heparin and pregnancy in women with a history of repeated miscarriages.Haemostasis, 23 Suppl 1
M. Galli, T. Barbui, P. Comfurius, C. Maassen, H. Hemker, R. Zwaal, E. Bevers, M. Baets, P.J.C. Breda-Vriesman (1990)
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 335
Lawrence Chamley, E. McKay, Neil Pattison (1993)
Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis.Thrombosis research, 71 2
A. Unander, R. Norberg, L. Hahn, L. Årfors (1987)
Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion.American journal of obstetrics and gynecology, 156 1
Eva Lester (1976)
SI CHAOSThe Lancet, 307
H. McNeil, R. Simpson, C. Chesterman, S. Krilis (1990)
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).Proceedings of the National Academy of Sciences of the United States of America, 87
L. Carreras, S. Machin, R. Deman, G. Defreyn, J. Vermylen, B. Spitz, A. Assche (1981)
ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATIONThe Lancet, 317
A. Trowbridge, J. Caraveo, Jacob Green, Barbara Amaral, M. Stone (1978)
Heparin-related immune thrombocytopenia. Studies of antibody-heparin specificity.The American journal of medicine, 65 2
M. Lockshin, M. Druzin, T. Qamar (1989)
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody.American journal of obstetrics and gynecology, 160 2
(1993)
A prospective controlled trial of aspirin alone (ASA) versus heparin (Hep) plus aspirin for the treatment of recurrent pregnancy loss associated with antiphospholipid antibodies (APA)
(1990)
Annotation: Antiphospholipid antibodies
PROBLEM: To determine if heparin may act directly with antiphospholipid antibodies (APA) to prevent recurrent pregnancy loss (RPL). METHOD: Patients were seen at the University of Texas Southwestern Medical Center. Twenty women with a history of RPL (≥3 miscarriages), positive APA, and an otherwise normal evaluation were treated with heparin in two daily subcutaneous dosages during a successful pregnancy. APA levels were obtained prior to conception and again at 6, 20, and 30 weeks. RESULTS: Heparin reduced APA binding to cardiolipin and phosphatidylserine in a dose‐dependent fashion in ELISA. Heparin affinity chromatography absorbed over 80% of the IgG anticardiolipin antibody in serum from women with high levels of APA. Women treated with increasing dosages of heparin during pregnancy had inversely decreasing levels of IgG anticardiolipin antibody. CONCLUSION: Heparin may act by directly binding APA in vivo, thereby decreasing the adverse effects of APA in women with APA associated RPL.
American Journal of Reproductive Immunology – Wiley
Published: Jan 1, 1995
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.